Document is current
Any future updates will be listed below
-
Authors
Shepard, Dale
Stern, Sydney
Bernthal, Nicholas M.
- License Information
-
More Information
Article History
Received: 5 February 2026
Accepted: 8 July 2026
First Online: 22 August 2026
Declarations
Conflict of Interest: Dale Shepard: Honorarium for educational presentations from Springworks, Deciphera, and Aadi; advisory boards with Springworks, Parabilis, Ipsen, Deciphera, Daiichi Sankyo, and Bayer; and institutional research funding as site principal investigator from Aadi, Cogent, Compugen, Deciphera, Eli Lilly, Inhibrx, Kinnate, Loxo, Novartis, NucMito, PMV Pharma, Pfizer, Polaris, Prelude, and Rain Therapeutics. Sydney Stern: No relevant disclosures. Nicholas M. Bernthal: Consulting/Advisory boards with Deciphera, Daiichi Sankyo, and EMD Serono. Research support from Zimmer Biomet, NIH, MSTS, OREF, and DOD.
Ethical Approval: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
